Being established in 1971, Kocak Pharmaceuticals has been part of the most prominent companies of the Turkish pharma sector for the past 46 years. Today, it has almost 1200 employees and over 500 different type of products and both API and finished product production.
The headquarters of the company are located in Istanbul. It has 11 regional offices and the "Sales Force" consists of approximately 400 employees. In 2000, the firm moved its production facilities to Cerkezkoy Organized Industrial Zone to a newly constructed 140,000 sqm production plant with an indoor area of 100,000 sqm. Raw materials and pharmaceuticals are produced in 2 different factories.
"We produce pharmaceuticals targeting many areas of medicine, specifically focusing on gynecology & obstetrics, urology, chest diseases (tuberculosis), cardiology, oncology and products of general health protection," says the company.
Kocak Farma has been exporting API and finished products to several countries and has been contracting manufacturing for local and international companies. Its aim is to share its experience and technology with new partners by contract manufacturing or export activities.
According to the corporate website, the production of Kocak Farma is in line with cGMP Guidelines and WHO standards. Kocak Farma has been certified by TUV Rheinland with DIN EN ISO 9001:2000 (Management of Quality System) Environmental Policy has been settled successfully ensuring total environmental safety qualifying the company for DIN EN ISO 14001:1999 Management of Environmental Systems Certificate given by TUV Rheinland.
LATEST issue 4/2022
Hannover Messe 2023’s lead theme ‘Industrial Transformation – Making the Difference’ will show the difference that exhibiting companies can make, which changes they can carry out and which innovations they can develop on the road to a climate-neutral industry. Learn more about the upcoming event from the latest issue 4/2022...
Romania’s Star Assembly, a fully-owned subsidiary of Mercedes-Benz, announced it will invest a nine-figure sum to extend its production portfolio and include the assembly of electric drive units for new generation Mercedes-EQ electric vehicles starting 2025...
Magna is expanding its footprint in Eastern Europe with the opening of a new facility in Struga, North Macedonia. Тhe new plant will support several European automakers. More details read in the latest issue 4/2022...